Cardiology Online Quiz -sep-18

25 Questions | Total Attempts: 412

SettingsSettingsSettings
Cardiology Online Quiz -sep-18 - Quiz

Cardiology Online Quiz -Sep-18


Questions and Answers
  • 1. 
    Olmesartan in Olkem beta offers _____relative risk reduction in CV Complications?
    • A. 

      85.2%

    • B. 

      68.5%

    • C. 

      82.4%

    • D. 

      None of the above

  • 2. 
    What is pay-off line of Olkem H
    • A. 

      For effective & sustained BP reduction

    • B. 

      Superior control & compliance

    • C. 

      BP control & Beyond

    • D. 

      Superior BP Control

  • 3. 
    In which indication is OLKEM beta prescribed?
    • A. 

      Elderly hypertension with diabetes

    • B. 

      Hypertension with CVD

    • C. 

      Uncontrolled hypertension

    • D. 

      Hypertension with IHD

  • 4. 
    Olkem reduced urinary protein to creatinine ratio >50% within_______ weeks
    • A. 

      12 Weeks

    • B. 

      16 Weeks

    • C. 

      14 Weeks

    • D. 

      None of the above

  • 5. 
    20 mmHg reduction in SBP offers 65% reduction in _________
    • A. 

      All-cause mortality

    • B. 

      CV events

    • C. 

      Stroke

    • D. 

      All of the above

  • 6. 
    In September Olkem LBL, which dose do we need to take beat Hypertension?
    • A. 

      Aspiration

    • B. 

      Confidence

    • C. 

      Passion

    • D. 

      Resolution

  • 7. 
    What is the input for Olkem in September month?
    • A. 

      Chit Pad

    • B. 

      Paper-weight

    • C. 

      Prescription pad

    • D. 

      Table Top

  • 8. 
    20 mmHg reduction in SBP offers 65% reduction in stroke
    • A. 

      Yes

    • B. 

      No

  • 9. 
    Jupiros offers _________reduction in LDL-C levels.
    • A. 

      Atorvastatin 10 mg

    • B. 

      Atorvastatin 20 mg

    • C. 

      Atorvastatin 5 mg

    • D. 

      Atorvastatin 40 mg

  • 10. 
    ALL in JUPIROS FOR ALL stands for?
    • A. 

      Astonishing lipid lowering

    • B. 

      Aggressive lipoprotein lowering

    • C. 

      Aggressive lipid lowering

    • D. 

      Apprehensive lipid lowering.

  • 11. 
    In which indication, Jupiros Gold stands for?
    • A. 

      ACS/IHD/Stroke

    • B. 

      In primary prevention of CV events

    • C. 

      In Dyslipidemia

    • D. 

      In Dyslipidemia with established CVD

  • 12. 
    Brand Payoff for Jupiros CV?
    • A. 

      Saves Money, Saves life.

    • B. 

      Saves money, Shields life.

    • C. 

      Saves money, Extends life.

    • D. 

      Saves money, Enhances life.

  • 13. 
    Clopidogrel and Aspiration combination is recommended by __________after cardiac events or PCI
    • A. 

      European Society of Cardiology

    • B. 

      American College of Cardiology

    • C. 

      American Heart Association

    • D. 

      Cardiology Society of India

  • 14. 
    Rosuvastatin in Jupiros Gold offers _______reduction in MI
    • A. 

      71%

    • B. 

      54%

    • C. 

      9.2%

    • D. 

      None of the above

  • 15. 
    Combination therapy of Jupiros F offers 44.8% reduction in TG levels
    • A. 

      No

    • B. 

      Yes

  • 16. 
    In the Jupiros September LBL, Aggressive lipid lowering reduces CV risk whether _____________?
    • A. 

      Small or big

    • B. 

      Big or Small

    • C. 

      Short & Tall

    • D. 

      None of the above

  • 17. 
    Which is the brand reminder of Jupiros for September month?
    • A. 

      Paper weight

    • B. 

      Table top

    • C. 

      Chit Pad

    • D. 

      None of the above

  • 18. 
    Cilnikem Brand Payoff line is?
    • A. 

      Compelling BP reduction with Protection

    • B. 

      All round benefits for better control

    • C. 

      Added Benefits for better control

    • D. 

      Additional blood pressure control

  • 19. 
    Cilnikem  reduces SBP by ________mmHg within 4 weeks of treatment
    • A. 

      12.23/11.6

    • B. 

      19.6/10.6

    • C. 

      11.33/10.6

    • D. 

      13.11/12.1

  • 20. 
    Brand reminder input of Cilnikem for the month of September is?
    • A. 

      Chit pad

    • B. 

      Prescription pad

    • C. 

      Tissue box

    • D. 

      Paper weight

  • 21. 
    Control is ________ over hypertension is mentioned on the Cilnikem LBL for the month of August 2018?
    • A. 

      Power

    • B. 

      Triumph

    • C. 

      Success

    • D. 

      Glory

  • 22. 
    In which indication Cilnikem Beta is prescribed?
    • A. 

      In Uncontrolled Hypertension

    • B. 

      In elderly Hypertension

    • C. 

      In Hypertension

    • D. 

      None of the above

  • 23. 
    Cilnidipine in  Cilnikem CT  reduced heart rate by ____bpm
    • A. 

      3.5

    • B. 

      4.6

    • C. 

      3.6

    • D. 

      None of the above

  • 24. 
    Cilnikem offers reduction in Heart rate
    • A. 

      No

    • B. 

      Yes

  • 25. 
    In Cilnikem Beta, Cilnidipine reduces aortic SBP by _____mmHg
    • A. 

      13.3

    • B. 

      13.7

    • C. 

      14.1

    • D. 

      14.2

Back to Top Back to top